Keyphrases
Antihypertensive Medication
9%
Atrial Fibrillation
21%
Back Pain
11%
Blood Pressure
14%
Chronic Obstructive Pulmonary Disease
30%
Clinical Efficacy
25%
Cluster Randomized Trial
25%
Corticosteroid Injection
13%
Cost-effectiveness
91%
Cost-effectiveness Analysis
25%
Cost-utility Analysis
16%
Decision-analytic Model
12%
Economic Evaluation
47%
General Practice
12%
General Practitioners
18%
Health-related Quality of Life
9%
Home-based
10%
Hypertension
9%
Hypertension Management
14%
Intervention Group
10%
Language Therapy
10%
Lee Silverman Voice Treatment
10%
Life-years Gained
12%
Musculoskeletal Pain
13%
Noninvasive Ventilation
10%
Osteoarthritis
13%
Parkinson's Disease
10%
Patient Self-management
9%
Physical Activity
11%
Physiotherapist
12%
Physiotherapy
14%
Pilot Randomized Controlled Trial
12%
Primary Care
85%
Primary Care Patients
9%
Quality of Life
10%
Quality-adjusted Life Years
34%
Randomized Controlled Trial
67%
Reach-to-grasp
10%
Review Evaluation
12%
Sciatica
10%
Self-management
26%
Self-monitoring
18%
Speech Therapy
10%
Stratified Care
9%
Systolic Blood Pressure
9%
Telemonitoring
14%
Transient Ischemic Attack
10%
Trial Registration
10%
Usual Care
44%
Well Groups
12%
Medicine and Dentistry
Adverse Event
11%
Anticoagulant Therapy
9%
Anticoagulation
15%
Antihypertensive Agent
10%
Apoplexy
26%
Arm
34%
Atrial Fibrillation
12%
Backache
12%
Blood Pressure
20%
Cardiovascular Disease
8%
Carpal Tunnel Syndrome
7%
Case Finding
13%
Chronic Obstructive Pulmonary Disease
49%
Clinician
8%
Cost-Effectiveness Analysis
83%
Diagnosis
7%
Drug Therapy
15%
General Medicine
8%
General Practitioner
10%
Health Care Cost
69%
Low and Middle Income Countries
7%
Low Back Pain
7%
Lung
11%
Mass Screening
7%
Musculoskeletal Pain
10%
National Health Service
6%
Nicotine Withdrawal
6%
Noninvasive Ventilation
10%
Outpatient
14%
Parkinson's Disease
12%
Patient Referral
9%
Physical Activity
8%
Physiotherapist
10%
Physiotherapy
14%
Polyp
7%
Polypectomy
6%
Primary Health Care
76%
Quality Adjusted Life Year
25%
Quality of Life
16%
Randomized Clinical Trial
8%
Randomized Controlled Trial
100%
Remote Patient Monitoring
11%
Sciatica
7%
Self Monitoring
16%
Speech and Language Rehabilitation
12%
Systematic Review
29%
Systolic Blood Pressure
8%
Titrimetry
7%
Transient Ischemic Attack
8%
Uterus Bleeding
7%
Nursing and Health Professions
Adverse Event
8%
Anticoagulant Therapy
10%
Anticoagulation
14%
Antihypertensive Agent
12%
Atrial Fibrillation
15%
Backache
12%
Base
8%
Blood Pressure
28%
Cardiovascular Disease
11%
Carpal Tunnel Syndrome
7%
Cerebrovascular Accident
26%
Clinical Effectiveness
24%
Cost Effectiveness Analysis
99%
Cost Utility Analysis
15%
Diagnosis
8%
Drug Therapy
10%
Economic Analysis
9%
Economic Evaluation
32%
General Practice
10%
General Practitioner
14%
Health Service
11%
Hospital
18%
Incremental Cost-Effectiveness Ratio
7%
Knee Osteoarthritis
10%
Mass Screening
7%
Musculoskeletal Pain
8%
Nicotine Withdrawal
7%
Noninvasive Ventilation
10%
Obstructive Lung Disease
34%
Osteoarthritis
14%
Outpatient
7%
Parkinson's Disease
12%
Patient Referral
7%
Physiotherapist
18%
Physiotherapy
24%
Practice Guideline
13%
Primary Medical Care
80%
Quality Adjusted Life Year
34%
Quality of Life
21%
Randomization
10%
Self Care
35%
Self Monitoring
18%
Socialized Medicine
8%
Speech and Language Rehabilitation
12%
Splint
7%
Systematic Review
31%
Systolic Blood Pressure
8%
Telemonitoring
14%
Titrimetry
9%
Transient Ischemic Attack
7%